Table 3.
METTS triage priority and the association with 90-day mortality and TNFR1 and TNFR2 in patients with diabetes
| Triage priority | 90-day mortality % (deceased/all) | TNFR (ng/mL (IQR)) | |
|---|---|---|---|
| TNFR-1 | TNFR-2 | ||
| Red (most acute) | 27.7% (13/47) | 3561 (3924) | 8555 (5277) |
| Orange | 11.8% (11/93) | 2595 (2758) | 7316 (6398) |
| Yellow | 9.9% (14/141) | 2746 (2362) | 6876 (5638) |
| Green (least acute) | 20.0% (2/10) | 3234 (3104) | 8483 (5470) |
Data are expressed as absolute risk % and median (IQR). Significance was tested using one-way ANOVA for sTNFR levels, and for 90-day mortality, a trend test was performed to analyze linearity between groups